Optimized stem cell treatment for Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial studies whether a special type of stem cell treatment can help people with Parkinson's disease or certain atypical parkinsonism conditions. The treatment involves harvesting your own bone marrow stem cells and optimizing them in the lab before giving them back to you. It aims to see if this can slow down the disease or improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have been diagnosed with Parkinson's disease or an atypical parkinsonism (like dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, or corticobasal degeneration) within the last 6 years.
- You can walk at least 25 meters (about 82 feet) without help.
- Your health has been stable for the past 60 days.
- You are able to attend study visits for 18 months and give informed consent.
- For Parkinson's disease: you must respond to levodopa or dopamine agonists, have mild to moderate symptoms (Hoehn and Yahr stage 3 or less), and have normal thinking skills (MoCA score of 26 or higher).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new stem cell treatment for Parkinson's disease. It aims to see if the treatment is safe and may help improve symptoms when current medications stop working well.
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
This trial tests a new treatment called NouvNeu001 for people with Parkinson's disease. It aims to see if it's safe, feasible, and effective in improving motor symptoms.
This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
Hear when a new Atypical Parkinsonism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.